Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22547887 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effects of Treatment of Sleep Apnea on Metabolic Syndrome
Conditions: Impaired Glucose Tolerance;   Obstructive Sleep Apnea
Interventions: Device: Continuous Positive Airway Pressure (CPAP) (Philips-Respironics RemStar Pro® CPAP);   Device: Sham-Continuous Positive Airway Pressure (CPAP) (Philips-Respironics)

Indicates status has not been verified in more than two years